Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4634 USD | +0.95% | -7.32% | -33.89% |
05-10 | Northwest Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-21 | Northwest Biotherapeutics, Inc. Appoints Pat Sarma to Its Board of Directors | CI |
Chart: Technical Analysis
- Stock Market
- Equities
- NWBO Stock
- Charts Northwest Biotherapeutics, Inc.